Additionally, the use of the combination of GW-2974 with a MET inhibitor, yielded maximum growth inhibition in the treatment of non-small cell lung carcinoma (NSCLC) than the use of any individual inhibitor [7]. This evidence concerns the gene MET and non-small cell lung carcinoma.